Adaptimmune Therapeutics PLC (ADAPY): Long-Term Debt
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$54.28M
As of 2024-12-31
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $54.28M | n/a | 2025-03-24, Balance as of period end |